| Literature DB >> 30983387 |
Nienke Ter Hoeve1,2, Madoka Sunamura1, Henk J Stam2, Ron T van Domburg3, Rita Jg van den Berg-Emons2.
Abstract
OBJECTIVE: In this secondary analysis of data from the OPTICARE trial, we compared the effects of two behavioral interventions integrated into cardiac rehabilitation to standard rehabilitation with regard to functional capacity, fatigue, and participation in society.Entities:
Keywords: Participation (WHO ICF); acute coronary syndrome; behavioral; lifestyle change; physical fitness
Mesh:
Year: 2019 PMID: 30983387 PMCID: PMC6613172 DOI: 10.1177/0269215519842216
Source DB: PubMed Journal: Clin Rehabil ISSN: 0269-2155 Impact factor: 3.477
Figure 1.Consort flow diagram.
CR+F, cardiac rehabilitation plus face-to-face group counseling; CR+T, cardiac rehabilitation plus individual telephonic counseling; CR-only, standard cardiac rehabilitation.
Participant baseline characteristics (n = 740).
| Characteristics | CR+F ( | CR+T ( | CR-only ( | Between-group differences |
|---|---|---|---|---|
| Male, | 202 (80.5) | 202 (82.4) | 196 (80.3) | 0.799 |
| Age, mean (SD), years | 57.5 (8.8) | 56.7 (9.2) | 57.5 (9.2) | 0.533 |
| Partnered, | 169 (80.5) | 168 (84.0) | 171 (83.4) | 0.599 |
| Employed, | 123 (64.7) | 112 (60.5) | 107 (56.0) | 0.220 |
| Therapeutic intervention index event, | 0.711 | |||
| No revascularization | 17 (6.8) | 24 (9.8) | 18 (7.4) | |
| Percutaneous coronary intervention | 201 (80.1) | 180 (73.5) | 193 (79.1) | |
| Coronary artery bypass graft | 33 (13.1) | 41 (16.7) | 33 (13.5) | |
| Cardiac history, | ||||
| Myocardial infarction | 20 (8) | 21 (8.6) | 20 (8.2) | 0.970 |
| Angina pectoris | 12 (4.8) | 14 (5.7) | 14 (5.7) | 0.865 |
| Percutaneous coronary intervention | 23 (9.2) | 23 (9.4) | 25 (10.2) | 0.912 |
| Coronary artery bypass graft | 3 (1.2) | 1 (0.4) | 5 (2.0) | 0.254 |
| Stroke/transient ischemic attack | 10 (4.0) | 3 (1.2) | 5 (2.0) | 0.122 |
| Medication, | ||||
| Acetylsalicylic acid | 240 (95.6) | 240 (98.0) | 237 (97.1) | 0.312 |
| Oral anticoagulant | 13 (5.2) | 17 (6.9) | 11 (4.5) | 0.478 |
| Thienopyridine | 211 (84.1) | 196 (80.0) | 210 (86.1) | 0.185 |
| Cholesterol lowering medication | 240 (95.6) | 236 (96.3) | 237 (97.1) | 0.668 |
| Beta-blocker | 208 (82.9) | 200 (81.6) | 200 (82.0) | 0.933 |
| ACE inhibitor | 181 (72.1) | 171 (69.8) | 169 (69.3) | 0.761 |
| Angiotensin II receptor blocker | 32 (12.7) | 31 (12.7) | 33 (13.5) | 0.952 |
| Calcium blocker | 34 (13.5) | 37 (15.1) | 36 (14.8) | 0.874 |
| Nitrate | 104 (41.4) | 76 (31.0) | 86 (35.2) | 0.052 |
| Diuretic | 27 (10.8) | 27 (11.0) | 24 (9.8) | 0.905 |
| Psychotropic | 11 (4.4) | 15 (6.1) | 16 (6.6) | 0.541 |
| Risk factors, | ||||
| Diabetes | 34 (13.5) | 24 (9.8) | 35 (14.3) | 0.268 |
| Dyslipidemia | 70 (27.9) | 87 (35.5) | 101 (41.4) | 0.007 |
| Family history | 134 (53.4) | 128 (52.2) | 136 (55.7) | 0.732 |
| Smoking history | 109 (43.4) | 95 (38.8) | 89 (36.5) | 0.272 |
| Hypertension | 109 (43.4) | 96 (39.2) | 98 (40.2) | 0.602 |
| Overweight | 194 (77.3) | 186 (75.9) | 187 (76.6) | 0.906 |
| Cardiac rehabilitation compliance | ||||
| Number of training sessions, mean (SD) | 23.5 (6.4) | 22.9 (5.2) | 23.0 (5.6) | 0.475 |
| Educational sessions, | 199 (79.2) | 185 (75.5) | 184 (75.4) | 0.844 |
| Counseling sessions, | 88 (35.0) | 82 (33.5) | 72 (28.7) | 0.539 |
| Additional face-to-face sessions, | 243 (96.8) | – | – | |
| Additional telephonic sessions, | – | 196 (80.0) | – | |
CR+F, cardiac rehabilitation plus face-to-face group counseling; CR+T, cardiac rehabilitation plus individual telephonic counseling; CR-only, standard cardiac rehabilitation.
Data missing for n = 41 (CR+F), n = 45 (CR+T), and n = 39 (CR-only).
Data missing for n = 61 (CR+F), n = 60 (CR+T), and n = 53 (CR-only).
Number of patients participating in at least one session.
Observed data for functional capacity, fatigue, and participation in society for all three groups.
| CR+F | CR+T | CR-only | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 3 months | 12 months | 18 months | Baseline | 3 months | 12 months | 18 months | Baseline | 3 months | 12 months | 18 months | |
| Functional capacity, mean ± SD | ||||||||||||
| 6MWT, m | 564 ± 82 | 608 ± 84 | 611 ± 87 | 600 ± 85 | 567 ± 76 | 601 ± 89 | 590 ± 75 | 597 ± 79 | 557 ± 80 | 598 ± 82 | 594 ± 76 | 596 ± 82 |
| Fatigue, mean ± SD | ||||||||||||
| FSS score | 3.29 ± 1.48 | 2.81 ± 1.30 | 2.62 ± 1.22 | 2.56 ± 1.18 | 3.32 ± 1.52 | 2.91 ± 1.38 | 2.82 ± 1.45 | 2.74 ± 1.33 | 3.33 ± 1.38 | 3.00 ± 1.37 | 2.78 ± 1.38 | 2.87 ± 1.46 |
| Fatigue, prevalence (%) | ||||||||||||
| Fatigue (FSS > 4.0) | 15.9 | 10.3 | 8.9 | 7.7 | 17.9 | 18.2 | 13.5 | 13.3 | 24.9 | 15.5 | 13.2 | 14.1 |
| Severe fatigue (FSS > 4.0) | 13.8 | 5.6 | 4.5 | 4.2 | 15.1 | 7.0 | 7.7 | 6.0 | 9.7 | 7.5 | 7.5 | 10.2 |
| Participation in society, mean ± SD | ||||||||||||
| Frequency score | 38.6 ± 11.1 | 37.2 ± 10.9 | 36.8 ± 9.6 | 36.5 ± 11.1 | 35.9 ± 10.6 | 37.3 ± 10.6 | 35.9 ± 11.9 | 36.2 ± 10.6 | 37.9 ± 10.7 | 36.7 ± 10.6 | 36.6 ± 10.4 | 36.2 ± 10.4 |
| Restriction score | 90.9 (22:100)[ | 100 (37:100)[ | 100 (7:100)[ | 100 ± (52:100)[ | 89.4 ± (6:100)[ | 100 ± (29:100)[ | 100 (41:100)[ | 100 (33:100)[ | 90.0 (10:100)[ | 100 (56:100)[ | 100 (0:100)[ | 100 (7:100)[ |
| Satisfaction score | 68.0 ± 15.6 | 73.8 ± 15.8 | 74.3 ± 14.2 | 74.5 ± 15.6 | 68.6 ± 14.8 | 74.5 ± 15.1 | 73.6 ± 15.8 | 76.3 ± 13.6 | 69.7 ± 15.9 | 73.4 ± 15.8 | 75.1 ± 16.0 | 73.8 ± 16.4 |
CR+F, cardiac rehabilitation plus face-to-face group counseling; CR+T, cardiac rehabilitation plus individual telephonic counseling; CR-only, standard cardiac rehabilitation; 6MWT, 6-minute walk test; FSS, Fatigue Severity Scale.
Scores violated normality assumption, therefore median (range) values are displayed.
Generalized estimating equation[a] results for intervention effects over all time-points, between baseline and 3 months, between baseline and 12 months, and between baseline and 18 months.
| CR+F vs. CR-only | CR+T vs. CR-only | ||||||
|---|---|---|---|---|---|---|---|
|
| CI |
| CI | ||||
| Functional capacity ( | |||||||
| 6MWT, m | Overall | 6.83 | −3.45, 17.12 | .192 | 3.82 | −14.39, 6.74 | .477 |
| ΔT0–3 months | 6.84 | −5.75, 19.43 | .287 | −0.14 | −13.77, 13.48 | .984 | |
| ΔT0–12 months |
|
|
| −9.20 | −20.89, 2.48 | .122 | |
| ΔT0–18 months | 1.54 | −11.86, 14.94 | .822 | −2.21 | −15.66, 11.24 | .747 | |
| Fatigue ( | |||||||
| FSS score | Overall | −0.16 | −0.35, 0.03 | .095 | −0.05 | −0.24, 0.14 | .619 |
| ΔT0–3 months | −0.13 | −0.35, 0.09 | .235 | −0.04 | −0.26, 0.18 | .708 | |
| ΔT0–12 months | −0.13 | −0.37, 0.11 | .296 | −0.02 | −0.28, 0.23 | .872 | |
| ΔT0–18 months | −0.24 | −0.49, 0.03 | .053 | −0.09 | −0.34, 0.15 | .453 | |
| Prevalence of fatigue (FSS > 4.0) | Overall |
|
|
| 0.95[ | 0.63, 1.45 | .832 |
| ΔT0–3 months | 0.75[ | 0.45, 1.23 | .260 | 1.07[ | 0.65, 1.77 | .778 | |
| ΔT0–12 months | 0.63[ | 0.35, 1.13 | .119 | 1.01[ | 0.57, 1.79 | .969 | |
| ΔT0–18 months |
|
|
| 0.76[ | 0.43, 1.35 | .356 | |
| Prevalence of severe fatigue (FSS > 5.2) | Overall | 0.55[ | 0.30, 1.01 | .056 | 0.70[ | 0.38, 1.28 | .250 |
| ΔT0–3 months | 0.72[ | 0.31, 1.63 | .428 | 0.83[ | 0.37, 1.84 | .644 | |
| ΔT0–12 months | 0.57[ | 0.24, 1.35 | .199 | 0.80[ | 0.34, 1.92 | .623 | |
| ΔT0–18 months |
|
|
| 0.53[ | 0.24, 1.17 | .117 | |
| Participation in society ( | |||||||
| Frequency score | Overall | −0.46 | −1.92, 1.01 | .540 | 0.73 | −0.71, 2.16 | .320 |
| ΔT0–3 months | −0.18 | −1.96, 1.60 | .842 | 0.98 | −0.79, 2.74 | .277 | |
| ΔT0–12 months | −1.06 | −2.92, 0.80 | .263 | −0.03 | −2.15, 2.08 | .977 | |
| ΔT0–18 months | −0.30 | −2.26, 1.65 | .760 | 1.10 | −0.77, 2.98 | .248 | |
| Restrictions score[ | Overall | 1.03[ | 0.73, 1.46 | .858 | 0.93[ | 0.66, 1.32 | .698 |
| ΔT0–3 months | 1.03[ | 0.68, 1.55 | .903 | 1.09[ | 0.70, 1.67 | .698 | |
| ΔT0–12 months | 0.95[ | 0.60, 1.51 | .824 | 0.82[ | 0.51, 1.30 | .386 | |
| ΔT0–18 months | 1.07[ | 0.67, 1.70 | .777 | 0.86[ | 0.54, 1.36 | .524 | |
| Satisfaction score | Overall | 0.32 | −1.93, 2.57 | .778 | 1.08 | −1.24, 3.39 | .361 |
| ΔT0–3 months | 0.67 | −1.96, 3.31 | .618 | 1.50 | −1.13, 4.12 | .264 | |
| ΔT0–12 months | −0.76 | −3.59, 2.06 | .596 | −0.72 | −3.68, 2.24 | .632 | |
| ΔT0–18 months | 1.40 | −1.84, 3.65 | .518 | 2.27 | −0.49, 5.02 | .107 | |
6MWT, 6-minute walk test; CI, confidence interval; CR+F, cardiac rehabilitation plus face-to-face group counseling; CR+T, cardiac rehabilitation plus individual telephonic counseling; CR-only, standard cardiac rehabilitation; FSS, Fatigue Severity Scale; n = number of patients who had at least one outcome post-baseline on the specified outcome and were included in the analysis.
Significance is P<0.05.
All analyses were adjusted for baseline differences between patients and corrected for confounding effects of gender and age. The CR-only group is the reference group for all analyses.
B, regression coefficient, represents the between-group difference and the intervention effect relative to CR-only over all time-points or at the specified time-point.
Odds ratios are shown for dichotomous variables to indicate the odds (relative risk) relative to CR-only at the specified time-point.
Scores violated normality assumption, dichotomized scores used for analysis.